Europe Diabetic Retinopathy Market Report 2021

September 2016 | 102 pages | ID: ECAADD0414FEN
QYResearch

Abstracts

This report studies sales (consumption) of Diabetic Retinopathy in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Bayer
• F. Hoffmann-La Roche
• Novartis
• Regeneron Pharmaceuticals
• Alimera Sciences
• Ampio Pharmaceuticals
• Kowa Group
• Ohr Pharmaceutical
• Promedior
• PSivida
• Quark Pharmaceuticals
• ThromboGenics

Market Segment by Regions, this report splits Europe into several key Regions, with sales (consumption), revenue, market share and growth rate of Diabetic Retinopathy in these regions, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Italy
• Spain
• Russia

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Corticosteroids drugs
• Anti-VEGF drugs
• Others

Split by applications, this report focuses on sales, market share and growth rate of Diabetic Retinopathy in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

1 DIABETIC RETINOPATHY OVERVIEW

1.1 Product Overview and Scope of Diabetic Retinopathy
1.2 Classification of Diabetic Retinopathy
  1.2.1 Corticosteroids drugs
  1.2.2 Anti-VEGF drugs
  1.2.3 Others
1.3 Applications of Diabetic Retinopathy
1.4 Diabetic Retinopathy Market by Regions
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Italy Status and Prospect (2011-2021)
  1.4.5 Spain Status and Prospect (2011-2021)
  1.4.6 Russia Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Diabetic Retinopathy (2011-2021)
  1.5.1 Europe Diabetic Retinopathy Sales, Revenue and Price (2011-2021)
  1.5.2 Europe Diabetic Retinopathy Sales and Growth Rate (2011-2021)
  1.5.3 Europe Diabetic Retinopathy Revenue and Growth Rate (2011-2021)

2 EUROPE DIABETIC RETINOPATHY BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Diabetic Retinopathy Market Competition by Manufacturers
  2.1.1 Europe Diabetic Retinopathy Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Diabetic Retinopathy Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Diabetic Retinopathy (Volume and Value) by Type
  2.2.1 Europe Diabetic Retinopathy Sales and Market Share by Type (2011-2021)
  2.2.2 Europe Diabetic Retinopathy Revenue and Market Share by Type (2011-2021)
2.3 Europe Diabetic Retinopathy (Volume and Value) by Regions
  2.3.1 Europe Diabetic Retinopathy Sales and Market Share by Regions (2011-2021)
  2.3.2 Europe Diabetic Retinopathy Revenue and Market Share by Regions (2011-2021)
2.4 Europe Diabetic Retinopathy (Volume) by Application

3 GERMANY DIABETIC RETINOPATHY (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Diabetic Retinopathy Sales and Value (2011-2021)
  3.1.1 Germany Diabetic Retinopathy Sales and Growth Rate (2011-2021)
  3.1.2 Germany Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
  3.1.3 Germany Diabetic Retinopathy Sales Price Trend (2011-2021)
3.2 Germany Diabetic Retinopathy Sales and Market Share by Manufacturers
3.3 Germany Diabetic Retinopathy Sales and Market Share by Type
3.4 Germany Diabetic Retinopathy Sales and Market Share by Applications

4 UK DIABETIC RETINOPATHY (VOLUME, VALUE AND SALES PRICE)

4.1 UK Diabetic Retinopathy Sales and Value (2011-2021)
  4.1.1 UK Diabetic Retinopathy Sales and Growth Rate (2011-2021)
  4.1.2 UK Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
  4.1.3 UK Diabetic Retinopathy Sales Price Trend (2011-2021)
4.2 UK Diabetic Retinopathy Sales and Market Share by Manufacturers
4.3 UK Diabetic Retinopathy Sales and Market Share by Type
4.4 UK Diabetic Retinopathy Sales and Market Share by Applications

5 FRANCE DIABETIC RETINOPATHY (VOLUME, VALUE AND SALES PRICE)

5.1 France Diabetic Retinopathy Sales and Value (2011-2021)
  5.1.1 France Diabetic Retinopathy Sales and Growth Rate (2011-2021)
  5.1.2 France Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
  5.1.3 France Diabetic Retinopathy Sales Price Trend (2011-2021)
5.2 France Diabetic Retinopathy Sales and Market Share by Manufacturers
5.3 France Diabetic Retinopathy Sales and Market Share by Type
5.4 France Diabetic Retinopathy Sales and Market Share by Applications

6 ITALY DIABETIC RETINOPATHY (VOLUME, VALUE AND SALES PRICE)

6.1 Italy Diabetic Retinopathy Sales and Value (2011-2021)
  6.1.1 Italy Diabetic Retinopathy Sales and Growth Rate (2011-2021)
  6.1.2 Italy Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
  6.1.3 Italy Diabetic Retinopathy Sales Price Trend (2011-2021)
6.2 Italy Diabetic Retinopathy Sales and Market Share by Manufacturers
6.3 Italy Diabetic Retinopathy Sales and Market Share by Type
6.4 Italy Diabetic Retinopathy Sales and Market Share by Applications

7 RUSSIA DIABETIC RETINOPATHY (VOLUME, VALUE AND SALES PRICE)

7.1 Russia Diabetic Retinopathy Sales and Value (2011-2021)
  7.1.1 Russia Diabetic Retinopathy Sales and Growth Rate (2011-2021)
  7.1.2 Russia Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
  7.1.3 Russia Diabetic Retinopathy Sales Price Trend (2011-2021)
7.2 Russia Diabetic Retinopathy Sales and Market Share by Manufacturers
7.3 Russia Diabetic Retinopathy Sales and Market Share by Type
7.4 Russia Diabetic Retinopathy Sales and Market Share by Applications

8 SPAIN DIABETIC RETINOPATHY (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Diabetic Retinopathy Sales and Value (2011-2021)
  8.1.1 Spain Diabetic Retinopathy Sales and Growth Rate (2011-2021)
  8.1.2 Spain Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
  8.1.3 Spain Diabetic Retinopathy Sales Price Trend (2011-2021)
8.2 Spain Diabetic Retinopathy Sales and Market Share by Manufacturers
8.3 Spain Diabetic Retinopathy Sales and Market Share by Type
8.4 Spain Diabetic Retinopathy Sales and Market Share by Applications

9 EUROPE DIABETIC RETINOPATHY MANUFACTURERS ANALYSIS

9.1 Bayer
  9.1.1 Company Basic Information,Manufacturing Base and Competitors
  9.1.2 Diabetic Retinopathy Product Type and Technology
    9.1.2.1 Type
    9.1.2.2 Type
  9.1.3 Diabetic Retinopathy Sales, Revenue, Price of Bayer (2015 and 2016)
9.2 F. Hoffmann-La Roche
  9.2.1 Company Basic Information,Manufacturing Base and Competitors
  9.2.2 Diabetic Retinopathy Product Type and Technology
    9.2.2.1 Type
    9.2.2.2 Type
  9.2.3 Diabetic Retinopathy Sales, Revenue, Price of F. Hoffmann-La Roche (2015 and 2016)
9.3 Novartis
  9.3.1 Company Basic Information,Manufacturing Base and Competitors
  9.3.2 Diabetic Retinopathy Product Type and Technology
    9.3.2.1 Type
    9.3.2.2 Type
  9.3.3 Diabetic Retinopathy Sales, Revenue, Price of Novartis (2015 and 2016)
9.4 Regeneron Pharmaceuticals
  9.4.1 Company Basic Information,Manufacturing Base and Competitors
  9.4.2 Diabetic Retinopathy Product Type and Technology
    9.4.2.1 Type
    9.4.2.2 Type
  9.4.3 Diabetic Retinopathy Sales, Revenue, Price of Regeneron Pharmaceuticals (2015 and 2016)
9.5 Alimera Sciences
  9.5.1 Company Basic Information,Manufacturing Base and Competitors
  9.5.2 Diabetic Retinopathy Product Type and Technology
    9.5.2.1 Type
    9.5.2.2 Type
  9.5.3 Diabetic Retinopathy Sales, Revenue, Price of Alimera Sciences (2015 and 2016)
9.6 Ampio Pharmaceuticals
  9.6.1 Company Basic Information,Manufacturing Base and Competitors
  9.6.2 Diabetic Retinopathy Product Type and Technology
    9.6.2.1 Type
    9.6.2.2 Type
  9.6.3 Diabetic Retinopathy Sales, Revenue, Price of Ampio Pharmaceuticals (2015 and 2016)
9.7 Kowa Group
  9.7.1 Company Basic Information,Manufacturing Base and Competitors
  9.7.2 Diabetic Retinopathy Product Type and Technology
    9.7.2.1 Type
    9.7.2.2 Type
  9.7.3 Diabetic Retinopathy Sales, Revenue, Price of Kowa Group (2015 and 2016)
9.8 Ohr Pharmaceutical
  9.8.1 Company Basic Information,Manufacturing Base and Competitors
  9.8.2 Diabetic Retinopathy Product Type and Technology
    9.8.2.1 Type
    9.8.2.2 Type
  9.8.3 Diabetic Retinopathy Sales, Revenue, Price of Ohr Pharmaceutical (2015 and 2016)
9.9 Promedior
  9.9.1 Company Basic Information,Manufacturing Base and Competitors
  9.9.2 Diabetic Retinopathy Product Type and Technology
    9.9.2.1 Type
    9.9.2.2 Type
  9.9.3 Diabetic Retinopathy Sales, Revenue, Price of Promedior (2015 and 2016)
9.10 PSivida
  9.10.1 Company Basic Information,Manufacturing Base and Competitors
  9.10.2 Diabetic Retinopathy Product Type and Technology
    9.10.2.1 Type
    9.10.2.2 Type
  9.10.3 Diabetic Retinopathy Sales, Revenue, Price of PSivida (2015 and 2016)
9.11 Quark Pharmaceuticals
  9.11.1 Company Basic Information,Manufacturing Base and Competitors
  9.11.2 Diabetic Retinopathy Product Type and Technology
    9.11.2.1 Type
    9.11.2.2 Type
  9.11.3 Diabetic Retinopathy Sales, Revenue, Price of Quark Pharmaceuticals (2015 and 2016)
9.12 ThromboGenics
  9.12.1 Company Basic Information,Manufacturing Base and Competitors
  9.12.2 Diabetic Retinopathy Product Type and Technology
    9.12.2.1 Type
    9.12.2.2 Type
  9.12.3 Diabetic Retinopathy Sales, Revenue, Price of ThromboGenics (2015 and 2016)

10 DIABETIC RETINOPATHY TECHNOLOGY AND DEVELOPMENT TREND

10.1 Diabetic Retinopathy Technology Analysis
10.2 Diabetic Retinopathy Technology Development Trend

11 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Diabetic Retinopathy
Table Classification of Diabetic Retinopathy
Figure Europe Sales Market Share of Diabetic Retinopathy by Types in 2015
Figure Corticosteroids drugs Picture
Figure Anti-VEGF drugs Picture
Figure Others Picture
Table Applications of Diabetic Retinopathy
Figure Europe Sales Market Share of Diabetic Retinopathy by Applications in 2015
Figure Germany Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
Figure France Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
Figure UK Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
Figure Italy Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
Figure Spain Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
Figure Russia Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
Table Europe Diabetic Retinopathy Sales, Revenue and Price (2011-2021)
Figure Europe Diabetic Retinopathy Sales and Growth Rate (2011-2021)
Figure Europe Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
Table Europe Diabetic Retinopathy Sales of Key Manufacturers (2015 and 2016)
Table Europe Diabetic Retinopathy Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Diabetic Retinopathy Sales Share by Manufacturers
Figure 2016 Diabetic Retinopathy Sales Share by Manufacturers
Table Europe Diabetic Retinopathy Revenue by Manufacturers (2015 and 2016)
Table Europe Diabetic Retinopathy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Diabetic Retinopathy Revenue Share by Manufacturers
Table 2016 Europe Diabetic Retinopathy Revenue Share by Manufacturers
Table Europe Diabetic Retinopathy Sales and Market Share by Type (2011-2021)
Table Europe Diabetic Retinopathy Sales Share by Type (2011-2021)
Figure Sales Market Share of Diabetic Retinopathy by Type (2011-2021)
Figure Europe Diabetic Retinopathy Sales Growth Rate by Type (2011-2021)
Table Europe Diabetic Retinopathy Revenue and Market Share by Type (2011-2021)
Table Europe Diabetic Retinopathy Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Diabetic Retinopathy by Type (2011-2021)
Figure Europe Diabetic Retinopathy Revenue Growth Rate by Type (2011-2021)
Table Europe Diabetic Retinopathy Sales and Market Share by Regions (2011-2021)
Table Europe Diabetic Retinopathy Sales Share by Regions (2011-2021)
Figure Sales Market Share of Diabetic Retinopathy by Regions (2011-2021)
Figure Europe Diabetic Retinopathy Sales Growth Rate by Regions (2011-2021)
Table Europe Diabetic Retinopathy Revenue and Market Share by Regions (2011-2021)
Table Europe Diabetic Retinopathy Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of Diabetic Retinopathy by Regions (2011-2021)
Figure Europe Diabetic Retinopathy Revenue Growth Rate by Regions (2011-2021)
Table Europe Diabetic Retinopathy Sales and Market Share by Application (2011-2021)
Table Europe Diabetic Retinopathy Sales Share by Application (2011-2021)
Figure Sales Market Share of Diabetic Retinopathy by Application (2011-2021)
Figure Europe Diabetic Retinopathy Sales Growth Rate by Application (2011-2021)
Figure Germany Diabetic Retinopathy Sales and Growth Rate (2011-2021)
Figure Germany Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
Figure Germany Diabetic Retinopathy Sales Price Trend (2011-2021)
Table Germany Diabetic Retinopathy Sales by Manufacturers (2015 and 2016)
Table Germany Diabetic Retinopathy Market Share by Manufacturers (2015 and 2016)
Table Germany Diabetic Retinopathy Sales by Type (2015 and 2016)
Table Germany Diabetic Retinopathy Market Share by Type (2015 and 2016)
Table Germany Diabetic Retinopathy Sales by Applications (2015 and 2016)
Table Germany Diabetic Retinopathy Market Share by Applications (2015 and 2016)
Figure UK Diabetic Retinopathy Sales and Growth Rate (2011-2021)
Figure UK Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
Figure UK Diabetic Retinopathy Sales Price Trend (2011-2021)
Table UK Diabetic Retinopathy Sales by Manufacturers (2015 and 2016)
Table UK Diabetic Retinopathy Market Share by Manufacturers (2015 and 2016)
Table UK Diabetic Retinopathy Sales by Type (2015 and 2016)
Table UK Diabetic Retinopathy Market Share by Type (2015 and 2016)
Table UK Diabetic Retinopathy Sales by Applications (2015 and 2016)
Table UK Diabetic Retinopathy Market Share by Applications (2015 and 2016)
Figure France Diabetic Retinopathy Sales and Growth Rate (2011-2021)
Figure France Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
Figure France Diabetic Retinopathy Sales Price Trend (2011-2021)
Table France Diabetic Retinopathy Sales by Manufacturers (2015 and 2016)
Table France Diabetic Retinopathy Market Share by Manufacturers (2015 and 2016)
Table France Diabetic Retinopathy Sales by Type (2015 and 2016)
Table France Diabetic Retinopathy Market Share by Type (2015 and 2016)
Table France Diabetic Retinopathy Sales by Applications (2015 and 2016)
Table France Diabetic Retinopathy Market Share by Applications (2015 and 2016)
Figure Italy Diabetic Retinopathy Sales and Growth Rate (2011-2021)
Figure Italy Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
Figure Italy Diabetic Retinopathy Sales Price Trend (2011-2021)
Table Italy Diabetic Retinopathy Sales by Manufacturers (2015 and 2016)
Table Italy Diabetic Retinopathy Market Share by Manufacturers (2015 and 2016)
Table Italy Diabetic Retinopathy Sales by Type (2015 and 2016)
Table Italy Diabetic Retinopathy Market Share by Type (2015 and 2016)
Table Italy Diabetic Retinopathy Sales by Applications (2015 and 2016)
Table Italy Diabetic Retinopathy Market Share by Applications (2015 and 2016)
Figure Russia Diabetic Retinopathy Sales and Growth Rate (2011-2021)
Figure Russia Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
Figure Russia Diabetic Retinopathy Sales Price Trend (2011-2021)
Table Russia Diabetic Retinopathy Sales by Manufacturers (2015 and 2016)
Table Russia Diabetic Retinopathy Market Share by Manufacturers (2015 and 2016)
Table Russia Diabetic Retinopathy Sales by Type (2015 and 2016)
Table Russia Diabetic Retinopathy Market Share by Type (2015 and 2016)
Table Russia Diabetic Retinopathy Sales by Applications (2015 and 2016)
Table Russia Diabetic Retinopathy Market Share by Applications (2015 and 2016)
Figure Spain Diabetic Retinopathy Sales and Growth Rate (2011-2021)
Figure Spain Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
Figure Spain Diabetic Retinopathy Sales Price Trend (2011-2021)
Table Spain Diabetic Retinopathy Sales by Manufacturers (2015 and 2016)
Table Spain Diabetic Retinopathy Market Share by Manufacturers (2015 and 2016)
Table Spain Diabetic Retinopathy Sales by Type (2015 and 2016)
Table Spain Diabetic Retinopathy Market Share by Type (2015 and 2016)
Table Spain Diabetic Retinopathy Sales by Applications (2015 and 2016)
Table Spain Diabetic Retinopathy Market Share by Applications (2015 and 2016)
Table Bayer Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of Bayer (2015 and 2016)
Table F. Hoffmann-La Roche Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of F. Hoffmann-La Roche (2015 and 2016)
Table Novartis Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of Novartis (2015 and 2016)
Table Regeneron Pharmaceuticals Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of Regeneron Pharmaceuticals (2015 and 2016)
Table Alimera Sciences Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of Alimera Sciences (2015 and 2016)
Table Ampio Pharmaceuticals Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of Ampio Pharmaceuticals (2015 and 2016)
Table Kowa Group Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of Kowa Group (2015 and 2016)
Table Ohr Pharmaceutical Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of Ohr Pharmaceutical (2015 and 2016)
Table Promedior Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of Promedior (2015 and 2016)
Table PSivida Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of PSivida (2015 and 2016)
Table Ampio Pharmaceuticals Basic Information List